Leaflet: Information for the user
Anaclosil 1000 mg powder for solution for injection
Cloxacillin (as sodium salt)
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
1. What Anaclosil is and what it is used for
2. What you need to know before you use Anaclosil
3. How to use Anaclosil
4. Possible side effects
The active substance of Anaclosil is cloxacillin.
Cloxacillin is an antibiotic belonging to the penicillin family.
Anaclosil is indicated for the treatment of the following infections:
Anaclosil is also indicated for the prevention of infections after neurological interventions such as internal cerebrospinal fluid diversion.
Do not take Anaclosil:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Anaclosil if you:
This medicine may interfere with laboratory tests: If you are going to have any diagnostic tests (including blood tests, urine tests, etc.), inform your doctor that you are taking this medicine, as it may alter the test results.
Children and adolescents
This medicine should be administered with caution in neonates, due to the risk of hyperbilirubinemia due to competition at the bilirubin binding sites to serum proteins.
Other medicines and Anaclosil
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. It is especially important that you inform your doctor if you are taking:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
This medicine passes into breast milk. Ask your doctor for advice before breastfeeding your baby. Treatment should be discontinued in case of diarrhea, candidiasis, or skin rashes in the baby.
Driving and using machines
There is no evidence of effects on the ability to drive or use machines.
Anaclosil contains sodium
This medicine contains 52.8 mg of sodium (main component of kitchen/table salt) per vial. This is equivalent to 2.7% of the maximum recommended daily dietary intake of sodium for an adult.
Anaclosil will be administered to you by a qualified healthcare professional (doctor or nurse).
It will be administered directly (by intravenous direct route) over 3-4 minutes or by drip into a vein (intravenous perfusion) over approximately 1 hour.
The recommended dose for adults will be as follows:
In case of severe kidney and liver problems, the dose administered will be half of the recommended dose.
Use in children and adolescents
The recommended dose is 100 to 200 mg per kilogram of body weight and per day, divided into 4-6 administrations, without exceeding 12 g per day.
If you are given too much Anaclosil
Tell your doctor or nurse immediately if you think you may have been given too much Anaclosil.
If you miss a dose of Anaclosil
Tell your doctor or nurse immediately if you think you may have missed a dose.
If you have any further questions on the use of this product, ask your doctor or nurse.
Like all medicines, Anaclosil can cause side effects, although not everybody gets them.
Very rare (may affect up to 1 in 10,000 people): severe skin redness, Stevens-Johnson syndrome, toxic epidermal necrolysis.
Frequency not known (cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
No special storage conditions are required.
Do not use this medicine after the expiry date which is stated on the carton, after EXP: The expiry date is the last day of the month stated.
Keep this medicine out of the sight and reach of children.
Once opened, this medicine should be used immediately. The reconstituted and diluted solution should be used immediately.
Do not use this medicine if you notice the presence of particles or if the reconstituted solution is cloudy.
Medicines should not be disposed of via wastewater or household waste. Place the cartons and any remaining medicines in the pharmacy's SIGRE collection point. If you have any further questions, ask your pharmacist how to dispose of the cartons and any remaining medicines. This will help protect the environment.
Composition of Anaclosil
The active substance is cloxacillin (as sodium salt). Each vial contains 1,000 mg of cloxacillin (as sodium salt).
Appearance of the product and contents of the pack
Anaclosil is a white or almost white powder for solution for injection and perfusion, packaged in a 10 mL glass vial.
For intravenous direct administration, the powder will be reconstituted in 4 mL of water for injections.
For continuous perfusion administration, the reconstituted powder in 4 mL of water for injections will be withdrawn from the vial and added to a bag of at least 100 mL of sodium chloride 9 mg/mL (0.9%) or glucose 50 mg/mL (5%) for perfusion in the hospital.
Anaclosil is available in packs of 1 or 100 vials.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Laboratorio Reig Jofre, S.A.
Gran Capitán, 10
08970 Sant Joan Despí (Barcelona)
This leaflet was last revised in August 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es
-------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Important: Consult the technical data sheet/summary of product characteristics before prescribing the medicine.
Anaclosil should be reconstituted with water for injections (for slow intravenous administration) and then diluted in at least 100 mL of sodium chloride 9 mg/mL (0.9%) or glucose 50 mg/mL (5%) for perfusion.
Sodium cloxacillin should not be used in perfusion bags containing protein hydrolysates, lipid suspensions, amino acids, blood, or serum.
The mixture of cloxacillin and aminoglycosides can cause substantial mutual inactivation, so they should not be mixed in the same perfusion bag.
Only limited data are available on the compatibility of Anaclosil with other substances for intravenous administration; consequently, no additives or other medicines should be added to the Anaclosil single-dose vials, nor should they be perfused simultaneously. If the same intravenous line is used for the sequential perfusion of different medicines, the line should be flushed before and after perfusion with a 0.9% sodium chloride solution.
Reconstitution
To prepare the solution for slow intravenous administration (3-4 minutes), an aseptic technique should be followed. Reconstitute the vial contents with 4 mL of water for injections, and gently rotate until the powder is completely dissolved. Avoid shaking or making rapid movements, as this could cause foam formation. The reconstituted product is stable for up to 6 hours at 25°C. From a microbiological point of view, the reconstituted product should be administered immediately by intravenous direct route or diluted immediately for continuous perfusion administration.
Dilution
For perfusion administration, the reconstituted solution should be diluted in at least 100 mL of sodium chloride 0.9% or glucose 5% solution for perfusion. Do not shake the bag. The resulting solution is a clear, colorless, or light yellow solution.
Perfusion
Check visually that the reconstituted solution does not contain particles before administration. Reconstituted solutions containing visible particles should be discarded.
Anaclosil should be administered as an intravenous perfusion over approximately 1 hour.
Anaclosil should not be mixed with other medicines.
Each vial is for single use only.